Department of Microbiology and Immunology, School of Basic Medicine, Shanxi Medical University, Jinzhong, China.
Department of Nephrology, Shanxi Provincial People's Hospital (Fifth Hospital) of Shanxi Medical University, Taiyuan, China.
Ren Fail. 2023 Dec;45(1):2186715. doi: 10.1080/0886022X.2023.2186715.
Renal ischemia-reperfusion injury(IRI)is a major cause of acute kidney injury(AKI), the injury and repair of renal tubular epithelial cells play an important role in the pathological process of IR-AKI. Metabolomics was used to detect cell metabolism alterations and metabolic reprogramming in the initial injury, peak injury, and recovery stage of human renal proximal tubular cells (HK-2 cells) to provide insights into clinical prevention and treatment of IRI-induced AKI.
An ischemia-reperfusion (H/R) injury and the recovery model of HK-2 cells were established at different times of hypoxia/reoxygenation. Comprehensive detection of metabolic alterations in HK-2 cells after H/R induction by nontarget metabolomics. Interconversion of glycolysis and fatty acid oxidation (FAO) in HK-2 cells after H/R induction was examined by western blotting and qRT-PCR.
Multivariate data analysis found significant differences among the groups, with significant changes in metabolites such as glutamate, malate, aspartate, and L-palmitoylcarnitine. Hypoxia-reoxygenated HK-2 cells are accompanied by altered metabolisms such as disturbance of amino acid and nucleotide metabolism, dysregulation of lipid metabolism, increased glycolysis, and metabolic reprogramming, which manifests as a shift in energy metabolism from FAO to glycolysis.
The development of IRI-induced AKI in HK-2 cells is accompanied by the disturbance of amino acid, nucleotide, and tricarboxylic acid cycle metabolism and specifically metabolic reprogramming of FAO to glycolytic conversion. The timely recovery of energy metabolism in HK-2 cells is of great significance for treating and prognosis IRI-induced AKI.
肾缺血再灌注损伤(IRI)是急性肾损伤(AKI)的主要原因,肾小管上皮细胞的损伤和修复在IRI-AKI 的病理过程中起着重要作用。代谢组学用于检测人近端肾小管细胞(HK-2 细胞)在初始损伤、峰值损伤和恢复阶段的细胞代谢改变和代谢重编程,为临床预防和治疗IRI 诱导的 AKI 提供思路。
在不同缺氧/复氧时间建立 HK-2 细胞的缺血再灌注(H/R)损伤和恢复模型。通过非靶向代谢组学综合检测 H/R 诱导后 HK-2 细胞的代谢改变。通过 Western blot 和 qRT-PCR 检测 H/R 诱导后 HK-2 细胞糖酵解和脂肪酸氧化(FAO)的相互转化。
多变量数据分析发现组间存在显著差异,谷氨酸、苹果酸、天冬氨酸和 L-棕榈酰肉碱等代谢物发生显著变化。缺氧复氧的 HK-2 细胞伴随着代谢的改变,如氨基酸和核苷酸代谢紊乱、脂质代谢失调、糖酵解增加和代谢重编程,表现为从 FAO 到糖酵解的能量代谢转移。
HK-2 细胞IRI 诱导 AKI 的发生伴随着氨基酸、核苷酸和三羧酸循环代谢的紊乱,以及 FAO 向糖酵解转化的特异性代谢重编程。HK-2 细胞能量代谢的及时恢复对治疗和预测 IRI 诱导的 AKI 具有重要意义。